- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00063596
Vitamin A Supplementation in Preterm Infants
Vitamin A Therapy in Preterm Infants: Vaccine Response
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Vitamin A and its derivative retinoic acid (RA) have been recognized as important factors in potentiating the immune response and protecting against infection. In developing nations, Vitamin A deficiency is associated with infectious gastroenteritis and increased susceptibility to a number of infections, such as measles. RA is an important regulator of cell growth and differentiation and can augment IgM production from core blood mononuclear cells in response to a polyclonal B-cell activator. This augmentation in immunoglobulin secretion is mediated by the effects of RA on both T and B cells, in part through the production of certain cytokines (e.g., IL-6 and IL-10) important in the terminal differentiation of B-cells to plasma cells. In animal models, correction of Vitamin A deficiency improves immune response to vaccination.
Infants with extremely low birth weight have low plasma and tissue concentrations of Vitamin A. Vitamin A supplementation of pre-term infants reduces chronic lung disease and the risk of sepsis. Because the immune system of the pre-term infant is immature, the response of pre-term infants to Hepatitis B vaccine is diminished compared to full-term babies. This study will determine whether Vitamin A supplementation of pre-term infants will enhance the response of these infants to immunization with Hepatitis B vaccine. The study will also evaluate the effect of Vitamin A supplementation on survival, chronic lung disease, and infection rate.
Low birth weight pre-term infants will be randomized to receive either Vitamin A supplementation or placebo. The Vitamin A treatment group will receive 5,000 IU of Vitamin A (retinyl palmitate) by intramuscular injection 3 times weekly for 28 days starting on postnatal day 2. To avoid pain and discomfort, the placebo group will receive a sham procedure rather than a placebo saline injection. The staff of the neonatal intensive care unit will retain the responsibility for decisions regarding the use of other therapies, such as parental fluids, mechanical ventilation, glucocorticoids, hyperalimentation, and blood replacement. All infants will be assessed for potential Vitamin A toxicity. While in the neonatal intensive care unit, infants will have blood tests at Days 0, 14, 30, and 60. After discharge from the neonatal intensive care unit, patients return for clinic assessment and blood samples at Months 4, 6, and 9. Infants will be given Hepatitis B vaccine at 2, 4, and 6 months chronological age. Primary outcome measures will include Hepatitis B antibody levels, chronic lung disease, rate of infection while in the neonatal intensive care unit, and the incidence and severity of infections during the first 9 months of life.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14222
- Women's and Children's Hospital of Buffalo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Born at less than 32 weeks gestation
- Weigh less than 1500 g (3.3 lbs) and more than 500 g (1.1 lbs)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Response to Hepatitis B vaccine
|
Secondary Outcome Measures
Outcome Measure |
---|
Length of hospital stay
|
Chronic lung disease
|
Respiratory and GI infections to 9 months of age
|
T-cell cytokine production and development
|
T-cell subset development
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mark Ballow, MD, State University of New York at Buffalo
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5R01HD037263 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Premature
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
Istituto Giannina GasliniEubrainRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
-
Instituto Nacional de Perinatologia Isidro Espinosa...UnknownImmune System Diseases | Premature Infant Disease | Immunoglobulin DeficiencyMexico
Clinical Trials on Vitamin A supplementation
-
Institut de Recherche en Sciences de la Sante,...Active, not recruitingMalaria | Malnutrition, ChildBurkina Faso
-
St. Jude Children's Research HospitalThe Gerber FoundationRecruiting
-
National Food Technology Research Centre, BotswanaNetherlands: Ministry of Health, Welfare and Sports; UNICEF; University of BotswanaUnknownAssessment of Vitamin A Status of Children
-
Centre for Food and Nutrition Research, YaoundeInternational Atomic Energy AgencyCompleted
-
Cheikh Anta Diop University, SenegalInternational Atomic Energy AgencyCompletedInfection | Vitamin A OverdoseSenegal
-
Johns Hopkins Bloomberg School of Public HealthJohns Hopkins University; United States Agency for International Development... and other collaboratorsCompletedVitamin A Deficiency | Mortality Through Six Months of AgeBangladesh
-
MARCELLUS SIMADIBRATACompletedMalnutrition | Nutritional Status | Body Mass Index | Nutrition Assessment | Hand Strength | HospitalIndonesia
-
IIMC, Riphah International University, PakistanNot yet recruitingGestational Diabetes MellitusPakistan
-
Instituto Nacional de Perinatologia Isidro Espinosa...University of Pennsylvania; Bill and Melinda Gates FoundationTerminatedPre-EclampsiaUnited States, Mexico
-
Wageningen UniversityZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedCognitive Decline | Cognitive SymptomsNetherlands